Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
MS, Biomedical Enterprise
2019
2019
Responsible for the day-to-day investment activities at Broadview Ventures, including identification and screening of new opportunities, due diligence, negotiation of deal structure, and portfolio company board involvement. Broadview is a mission-driven fund whose primary investment goal is to improve human health in the areas of cardiovascular disease and stroke. With 37 such investments since 2008, Broadview has considerable experience in the seed/early-stage space.
2020
Antag Therapeutics is a Copenhagen-based preclinical stage biotechnology company focused on developing therapies for dietary-related metabolic diseases. The company’s current lead therapy is a glucose-dependent insulinotropic peptide receptor (GIPR) antagonist for inducing weight loss in obese patients with Type-2 Diabetes.
2020
2020
Basking Biosciences, Inc. is developing the first reversible thrombolytic therapy for Acute Ischemic Stroke (AIS). Basking is focused on exploiting the properties of RNA biology to develop aptamers with high affinity and specificity against proteins involved in coagulation and hemostasis.
2020 - 2021
2020 - 2021
Renovacor is a preclinical stage biotechnology company whose mission is to develop improved therapies for genetically derived cardiovascular diseases. The company is currently developing a gene therapy for a rare, familial form of dilated cardiomyopathy due to mutation in the BAG3 gene.
2015 - 2019
2018 - 2019
2017 - 2018
2015 - 2017
- Play key role in building commercial analytic capabilities for Merrimack's first product launch in oncology - Analytics lead for Northeast and Southeast Regions, act as strategic thought partner with Field to develop actionable business recommendations in order to drive ONIVYDE adoption - Supported cross-functional teams in Marketing, Product Availability and Market Access, Commercial IT, among others, in critical business decision-making, Communicate key findings to a broad range of key stakeholders
2012 - 2015
2012 - 2015
Strategic life science consultant with experience across multiple therapeutic areas and project types, including: - Commercial opportunity assessments and forecasting - New product launch planning - Competitive assessments - BD&L opportunity assessments Skills include primary and secondary market research, forecasting, project management
2011 - 2011
2011 - 2011
2010 - 2010
2010 - 2010
Business Development
2007 - 2009
2007 - 2009
Laboratory of Genetic Neuropharmacology